VSTM2L and cancer: Significant correlations were also observed between VSTM2L upregulation and decreased TMB in other 10 cancer types (CESC, HNSC, LGG, LIHC, LUSC, READ, SARC, SKCM, THYM, and UCS) and increased TMB in four cancer types (ACC, KIRP, PRAD, and THCA).